Oxford University trial welcome news for patients in the fight against coronavirus
There has been another positive step forward in our fight against coronavirus this week, writes Dr Thilian Bartholomeuz (pictured) in his latest column.
A trial by Oxford University has found that an anti-inflammatory drug that was already commonly used in the UK reduces the risk of death in hospitalised patients with coronavirus who need oxygen.
The drug, called dexamethasone, reduces the risk of death in coronavirus patients on ventilation by as much as 35% and patients on oxygen by 20%.
More by this authorDan Churcher
This website and its associated newspaper are members of the Independent Press Standards Organisation (IPSO)